In order to verify whether ZEB1-AS1 affected the biological function of HCC cells through miR-23c targeted binding, the miR-23c inhibitor was transfected into SK-HEP-1 and JHH-7 cells, respectively. The gene discussed is ZEB1; the disease is hepatocellular carcinoma.